The word on San Francisco’s famously hilly streets is that big pharma is ready to go shopping in 2025, following a flurry of ...

After two years characterized by layoffs, pipeline reorganizations, FDA delays and clinical holds, Novavax CEO John Jacobs ...

Navi Finserv will use the funds to expand and grow its digital personal loan business, leveraging new technological advancements to strengthen its position in India's expanding digital lending sector.

President Donald Trump’s “drill, baby, drill” call for a resurgence in United States oil production will be frustrated by the ...

Barclays analyst Balaji Prasad maintained a Buy rating on Zoetis (ZTS – Research Report) today and set a price target of $242.00. The company’s ...

Veritone, Inc. , a leader in building human-centered enterprise AI solutions, today released its analysis of Q4 2024 and annual 2024 aggregated U.S. Bureau of Labor Statistics (BLS) Jobs Reports, ...

POTOMAC, MD / ACCESS Newswire / January 28, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") is proud to announce its selection as one of the top 15 finalists in the PREPARE ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Stockholm Exergi secures SEK 20 billion funding to develop Europe’s largest bio-CCS facility, aiming to capture 800,000 tonnes of CO2 annually.

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...